Open AccessCOVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes
Author(s) -
Germaine Wong,
Matthew Rowlandson,
Dharshana Sabanayagam,
Andrew N. Ginn,
Kathy Kable,
Frederika Sciberras,
Eric Au,
Jenny Draper,
Alicia Arnott,
Vitali Sintchenko,
Dominic E. Dwyer,
Sharon C.-A. Chen,
Jen Kok
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004203
Subject(s) - medicine , cohort , odds ratio , kidney disease , sore throat , myalgia , kidney , gastroenterology , immunology
Since November 2021, a new variant of concern (VOC), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.529 (Omicron) has emerged as the dominant coronavirus disease 2019 (COVID-19) infection worldwide. We describe the clinical presentation, risk factors, and outcomes in a cohort of kidney and kidney pancreas transplant recipients with COVID-19 caused by Omicron infection.